PI3K-AKT signaling may also be activated in melanoma due to loss of function of the negative regulator PTEN, which occurs in 10–30% of cutaneous melanomas, leading to constitutive activation of the PI3K pathway. The gene discussed is AKT1; the disease is melanoma.